Therapeuticsmd Inc Asset Turnover Ratio (TXMD), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Therapeuticsmd Inc   (NASDAQ: TXMD)
 

Therapeuticsmd Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Therapeuticsmd Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.09 in the second quarter (Jun 30 2026)

Within sector 163 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 3207, from total ranking in the first quarter 2026 at 3780.

Asset Turnover Ratio Definition



TXMD Asset Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Asset Change -2.53 % -1.71 % -81.6 % 15.15 % 8.93 %
Y / Y Revenue Change -8.72 % 84.22 % 33.88 % 43.33 % 306.84 %
Asset Turnover Ratio (TTM) 0.09 0.09 0.08 0.03 0.03
TXMD's Total Ranking # 3207 # 3780 # 3466 # 3559 # 3642
Seq. Asset Change -0.14 % -0.2 % -2.62 % 0.43 % 0.7 %
Seq. Revenue Change 20.03 % -18.92 % 13.9 % -17.65 % 142.24 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 164
Healthcare Sector # 482
Overall Market # 3207

Asset Turnover Ratio Statistics
High Average Low
1.35 0.24 0.02
(Jun 30 2012)   (Jun 30 2024)







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Elutia Inc   0.24 $ 11.353  Millions$ 47.654  Millions
Retractable Technologies Inc  0.24 $ 33.488  Millions$ 142.089  Millions
Alpha Cognition Inc.  0.23 $ 15.261  Millions$ 64.950  Millions
Bio Green Med Solution Inc   0.23 $ 1.861  Millions$ 7.940  Millions
Personalis Inc   0.23 $ 69.669  Millions$ 303.633  Millions
Petvivo Holdings Inc   0.23 $ 1.182  Millions$ 5.211  Millions
Biocorrx Inc   0.23 $ 0.787  Millions$ 3.478  Millions
Sutro Biopharma Inc   0.22 $ 45.702  Millions$ 204.985  Millions
Enanta Pharmaceuticals Inc  0.22 $ 65.258  Millions$ 293.260  Millions
Cannapharmarx Inc   0.21 $ 1.699  Millions$ 8.027  Millions
Autolus Therapeutics Plc  0.21 $ 117.390  Millions$ 567.827  Millions
Beyond Air Inc   0.21 $ 6.677  Millions$ 32.326  Millions
Ideaya Biosciences Inc   0.20 $ 234.127  Millions$ 1,158.627  Millions
Dariohealth Corp   0.20 $ 21.196  Millions$ 106.918  Millions
Safe Pro Group Inc   0.20 $ 2.881  Millions$ 14.769  Millions
60 Degrees Pharmaceuticals Inc   0.19 $ 1.111  Millions$ 5.775  Millions
Moderna Inc   0.19 $ 2,228.000  Millions$ 11,730.500  Millions
4d Molecular Therapeutics Inc   0.18 $ 92.008  Millions$ 499.053  Millions
Nrx Pharmaceuticals Inc   0.18 $ 3.394  Millions$ 18.504  Millions
Bioadaptives Inc   0.18 $ 0.026  Millions$ 0.141  Millions
Renovorx Inc   0.18 $ 1.976  Millions$ 11.184  Millions
Coya Therapeutics Inc   0.18 $ 8.019  Millions$ 45.643  Millions
Ligand Pharmaceuticals Incorporated  0.17 $ 290.542  Millions$ 1,688.847  Millions
Septerna Inc   0.17 $ 98.882  Millions$ 584.816  Millions
Inspiremd Inc   0.17 $ 10.502  Millions$ 62.247  Millions
Skinvisible Inc   0.16 $ 0.020  Millions$ 0.126  Millions
Maxcyte inc   0.16 $ 31.051  Millions$ 198.782  Millions
Abeona Therapeutics Inc   0.15 $ 30.093  Millions$ 207.166  Millions
Standard Biotools Inc   0.14 $ 83.691  Millions$ 593.430  Millions
Femasys Inc   0.14 $ 2.299  Millions$ 16.450  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.